Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Pharmacokinetic and Pharmacodynamic Study of AR882 in Adult Volunteers With Various Degrees of Renal Impairment

NCT04646889 is registered in ClinicalTrials.gov with Arthrosi Therapeutics as lead sponsor.

NCT NCT04646889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04646889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Pharmacokinetic and Pharmacodynamic Study of AR882 in Adult Volunteers With Various Degrees of Renal Impairment
Lead sponsor
Arthrosi Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
January 14, 2021
Completion date
June 27, 2022
Enrollment
46 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

renal impairment